These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10650326)

  • 1. Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico.
    Colonna P; Iliceto S
    Am Heart J; 2000 Feb; 139(2 Pt 3):S124-30. PubMed ID: 10650326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.
    Iliceto S; Scrutinio D; Bruzzi P; D'Ambrosio G; Boni L; Di Biase M; Biasco G; Hugenholtz PG; Rizzon P
    J Am Coll Cardiol; 1995 Aug; 26(2):380-7. PubMed ID: 7608438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of post-infarction remodelling with L-carnitine: multicenter study CEDIM (L-Carnitine digital echocardiography myocardial infarction)].
    Rizzon P; Iliceto S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):31-5. PubMed ID: 7634289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction.
    Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN
    Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial.
    Tarantini G; Scrutinio D; Bruzzi P; Boni L; Rizzon P; Iliceto S
    Cardiology; 2006; 106(4):215-23. PubMed ID: 16685128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infarct-related artery patency and long-term effects on left ventricular remodelling.
    Visser CA
    Cardiology; 1997; 88 Suppl 1():26-35; discussion 36. PubMed ID: 9118165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials.
    Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E
    G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A digital network for long-distance echocardiographic image and data transmission in clinical trials: the CEDIM (Carnitina, Ecocardiografia Digitalizzata, Infarto Miocardico) study experience.
    Iliceto S; D'Ambrosio G; Scrutinio D; Marangelli V; Boni L; Rizzon P
    J Am Soc Echocardiogr; 1993; 6(6):583-92. PubMed ID: 8311965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Post-Myocardial Infarction Pacing Remodeling Prevention Therapy (PRomPT) Trial: Design and Rationale.
    Chung ES; Fischer TM; Kueffer F; Anand IS; Bax JJ; Gold MR; Gorman RC; Theres H; Udelson JE; Stancak B; Svendsen JH; Stone GW; Leon A
    J Card Fail; 2015 Jul; 21(7):601-7. PubMed ID: 25795507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
    Blom AS; Pilla JJ; Gorman RC; Gorman JH; Mukherjee R; Spinale FG; Acker MA
    Heart Fail Rev; 2005 Jun; 10(2):125-39. PubMed ID: 16258720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction.
    Baur LH; Schipperheyn JJ; van der Wall EE; van der Velde EA; Schalij MJ; van Eck-Smit BL; van der Laarse A; Voogd PJ; Sedney MI; Reiber JH; Bruschke AV
    Eur Heart J; 1997 Aug; 18(8):1313-21. PubMed ID: 9458425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.
    Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; Liu J; Gibson CM; Harrison RW; Joseph DS; Heyrman R; Krucoff MW
    Am Heart J; 2015 Nov; 170(5):929-37. PubMed ID: 26542501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction.
    Bolognese L; Cerisano G; Buonamici P; Santini A; Santoro GM; Antoniucci D; Fazzini PF
    Circulation; 1997 Nov; 96(10):3353-9. PubMed ID: 9396427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of reperfusion post-infarction ventricular remodeling: new MRI insights.
    Springeling T; Uitterdijk A; Rossi A; Gorsse-Bakker C; Wielopolski PA; van der Giessen WJ; Krestin GP; de Feyter PJ; Duncker DJ; van Geuns RJ
    Int J Cardiol; 2013 Nov; 169(5):354-8. PubMed ID: 24182681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction.
    Chareonthaitawee P; Christian TF; Hirose K; Gibbons RJ; Rumberger JA
    J Am Coll Cardiol; 1995 Mar; 25(3):567-73. PubMed ID: 7860898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.